MetaboDay 2025

Un congrès autour du Métabolisme et de la Métabolomique aura lieu en Nouvelle-Aquitaine sur le site du Haut Carré de l’université de Bordeaux à Talence le 29 septembre.

🕰️ de 8h45 à 17h30

Au programme cette année :

Quatre intervenants de renom, qui présenteront leurs recherches de pointe et leurs analyses :

  • Pierre-Yves Plaçais (UMR 8249 CNRS, ESPCI Paris – Université Paris Sciences & Lettres)
    Brain energy metabolism in drosophila
  • Clotilde Alves-Guerra (Université Paris Cité, Institut Cochin, INSERM, CNRS)
    Role of the mitochondrial transporter UCP2 in the metabolic plasticity of the lymphocyte microenvironment in colorectal cancer
  • Michel Salzet (Université de Lille et CHU de Lille, INSERM U1192)
    The contribution of metabolomics-based SpiderMass technology combined with artificial intelligence in cancer diagnosis and prognosis
  • Didier Lacombe (University of Bordeaux, INSERM U1211, Bordeaux)
    ASMD B (Niemann-Pick disease type B): From diagnosis to therapy

Ainsi qu’une table ronde avec les plateformes SAMBordeaux MétabolomeLaboratoire L3 (UB’L3) et IC2MP.

L’inscription à l’événement est gratuite, mais obligatoire pour assister.

Date limite pour l’inscription : 9 septembre 2025

English version 🇬🇧

MetaboDay 2025

A conference on Metabolism and Metabolomics will be held in the Nouvelle-Aquitaine region at the Haut Carré site of the University of Bordeaux in Talence on September 29.

🕰️ from 8:45 a.m. to 5:30 p.m.

On the program this year:

Four renowned speakers, presenting their cutting-edge research and analysis:

  • Pierre-Yves Plaçais (UMR 8249 CNRS, ESPCI Paris – Université Paris Sciences & Lettres)
    Brain energy metabolism in drosophila
  • Clotilde Alves-Guerra (Université Paris Cité, Institut Cochin, INSERM, CNRS)
    Role of the mitochondrial transporter UCP2 in the metabolic plasticity of the lymphocyte microenvironment in colorectal cancer
  • Michel Salzet (University of Lille and Lille University Hospital, INSERM U1192)
    The contribution of metabolomics-based SpiderMass technology combined with artificial intelligence in cancer diagnosis and prognosis
  • Didier Lacombe (University of Bordeaux, INSERM U1211, Bordeaux)
    ASMD B (Niemann-Pick disease type B): From diagnosis to therapy

As well as a round table discussion with the SAM, Bordeaux Métabolome, Laboratoire L3 (UB’L3) and IC2MP platforms.

Registration for the event is free, but compulsory to attend.

Registration deadline: September 9, 2025